Insulet (PODD) Cash & Current Investments (2010 - 2026)
Insulet (PODD) reported Cash & Current Investments of $480.4 million for Q1 2026, down 62.56% on a YoY basis from $1.3 billion in Q1 2025, and down 32.91% quarter-over-quarter from $716.1 million in Q4 2025.
Insulet (PODD) Cash & Current Investments (2010 - 2026) Analysis & Trends
Insulet has reported Cash & Current Investments for 17 years, with the latest figure at $480.4 million in Q1 2026.
- For the quarter ending Q1 2026, Cash & Current Investments fell 62.56% year-over-year to $480.4 million; the trailing twelve-month figure through Mar 2026 stood at $480.4 million (down 62.56% YoY), and the FY2025 full-year result was $716.1 million, down 24.89% from the prior year.
- Cash & Current Investments for Q1 2026 stood at $480.4 million, down from $716.1 million in the prior quarter.
- The five-year high for Cash & Current Investments was $1.3 billion in Q1 2025, with the low at $480.4 million in Q1 2026.
- Historically, Cash & Current Investments has averaged $782.7 million across 5 years, with a median of $716.1 million in 2025.
- Annual changes were most pronounced in 2025 — Cash & Current Investments surged 70.81% — and 2026, when it sank 62.56%.
- Insulet's Cash & Current Investments stood at $675.2 million in 2022, then rose by 4.3% to $704.2 million in 2023, then jumped by 35.39% to $953.4 million in 2024, then slipped by 24.89% to $716.1 million in 2025, then tumbled by 32.91% to $480.4 million in 2026.
- The last three Cash & Current Investments figures came in at $480.4 million (Q1 2026), $716.1 million (Q4 2025), and $757.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 7.30 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 2.88 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 8.38 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.45 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 3.67 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 3.12 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 1.12 Bn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 2.29 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 439.60 Mn |
| 10 | Insulet | 10.20 Bn | 9.72 Bn | 529.10 Mn | 480.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 480.40 Mn |
| Dec 31, 2025 | 716.10 Mn |
| Sep 30, 2025 | 757.40 Mn |
| Jun 30, 2025 | 1.12 Bn |
| Mar 31, 2025 | 1.28 Bn |
| Dec 31, 2024 | 953.40 Mn |
| Sep 30, 2024 | 902.60 Mn |
| Jun 30, 2024 | 821.00 Mn |
| Mar 31, 2024 | 751.20 Mn |
| Dec 31, 2023 | 704.20 Mn |
| Sep 30, 2023 | 701.00 Mn |
| Jun 30, 2023 | 675.50 Mn |
| Mar 31, 2023 | 620.70 Mn |
| Dec 31, 2022 | 675.20 Mn |
| Sep 30, 2022 | 722.50 Mn |
| Jun 30, 2022 | 709.80 Mn |
| Mar 31, 2022 | 710.70 Mn |
| Dec 31, 2021 | 793.20 Mn |
| Sep 30, 2021 | 857.10 Mn |
| Jun 30, 2021 | 872.10 Mn |